10-K Filing

GLOBAL MEDICAL REIT INC. CIK: 1533615 FY 2012

Filing Information

Form Type	10-K
Accession Number	`0001078782-12-003029`
Period End Date	20120831
Filing Date	20121129
Fiscal Year	2012
Fiscal Period	FY
XBRL Instance	scoo-20120831.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 31 Income Statement 13 Cash Flow Statement 36

Balance Sheet 31 line items

Line Item	Tag	Value	Unit	Period
Common Stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common Stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common Stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$47.42K	USD	Point-in-time
Common Stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$12.31K	USD	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	-	USD	Point-in-time
Common Stock, shares issued	`CommonStockSharesIssued`	5.50M	shares	Point-in-time
Prepaid Expenses	`PrepaidExpenseCurrent`	-	USD	Point-in-time
Common Stock, shares issued	`CommonStockSharesIssued`	5.50M	shares	Point-in-time
Prepaid Expenses	`PrepaidExpenseCurrent`	$7.50K	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$12.31K	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$54.92K	USD	Point-in-time
Common Stock, shares outstanding	`CommonStockSharesOutstanding`	5.50M	shares	Point-in-time
Common Stock, shares outstanding	`CommonStockSharesOutstanding`	5.50M	shares	Point-in-time
Accrued liabilities	`AccruedLiabilitiesCurrent`	$7.50K	USD	Point-in-time
Accrued liabilities	`AccruedLiabilitiesCurrent`	-	USD	Point-in-time
Due to related parties	`DueToRelatedPartiesCurrent`	$380.00	USD	Point-in-time
Due to related parties	`DueToRelatedPartiesCurrent`	$380.00	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$7.88K	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$380.00	USD	Point-in-time
Common stock Authorized: 200,000,000 shares, par value $0.001 5,500,000 share issued and outstanding	`CommonStockValue`	$5.50K	USD	Point-in-time
Common stock Authorized: 200,000,000 shares, par value $0.001 5,500,000 share issued and outstanding	`CommonStockValue`	$5.50K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$49.50K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$49.50K	USD	Point-in-time
Deficit accumulated during the development stage	`DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage`	$-50.57K	USD	Point-in-time
Deficit accumulated during the development stage	`DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage`	$-459.00	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$54.54K	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$4.43K	USD	Point-in-time
Total Liabilities and Stockholders' Equity	`LiabilitiesAndStockholdersEquity`	$54.92K	USD	Point-in-time
Total Liabilities and Stockholders' Equity	`LiabilitiesAndStockholdersEquity`	$12.31K	USD	Point-in-time

Income Statement 13 line items

Line Item	Tag	Value	Unit	Period
General and administrative	`GeneralAndAdministrativeExpense`	$459.00	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$50.11K	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$50.57K	USD	6 Qtrs
Total Operating Expenses	`OperatingExpenses`	$50.11K	USD	Annual
Total Operating Expenses	`OperatingExpenses`	$459.00	USD	2 Qtrs
Total Operating Expenses	`OperatingExpenses`	$50.57K	USD	6 Qtrs
Net Loss	`NetIncomeLoss`	$-50.57K	USD	6 Qtrs
Net Loss	`NetIncomeLoss`	$-50.11K	USD	Annual
Net Loss	`NetIncomeLoss`	$-459.00	USD	2 Qtrs
Net Loss Per Share - Basic and Diluted	`EarningsPerShareBasicAndDiluted`	-	USD	2 Qtrs
Net Loss Per Share - Basic and Diluted	`EarningsPerShareBasicAndDiluted`	$-0.01	USD	Annual
Weighted Average Shares Outstanding	`WeightedAverageNumberOfSharesOutstandingBasic`	5.50M	shares	Annual
Weighted Average Shares Outstanding	`WeightedAverageNumberOfSharesOutstandingBasic`	323,864.00	shares	2 Qtrs

Cash Flow Statement 36 line items

Line Item	Tag	Value	Unit	Period
Net loss'	`ProfitLoss`	$-459.00	USD	2 Qtrs
Net loss'	`ProfitLoss`	$-50.11K	USD	Annual
Net loss'	`ProfitLoss`	$-50.57K	USD	6 Qtrs
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$-7.50K	USD	2 Qtrs
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$7.50K	USD	Annual
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	-	USD	6 Qtrs
Accrued liabilities	`IncreaseDecreaseInAccruedLiabilities`	-	USD	2 Qtrs
Accrued liabilities	`IncreaseDecreaseInAccruedLiabilities`	$7.50K	USD	6 Qtrs
Accrued liabilities	`IncreaseDecreaseInAccruedLiabilities`	$7.50K	USD	Annual
Net Cash Used in Operating Activities	`NetCashProvidedByUsedInOperatingActivities`	$-7.96K	USD	2 Qtrs
Net Cash Used in Operating Activities	`NetCashProvidedByUsedInOperatingActivities`	$-35.11K	USD	Annual
Net Cash Used in Operating Activities	`NetCashProvidedByUsedInOperatingActivities`	$-43.07K	USD	6 Qtrs
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$55.00K	USD	2 Qtrs
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$55.00K	USD	6 Qtrs
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	-	USD	Annual
Proceeds from related party debt	`ProceedsFromRelatedPartyDebt`	$380.00	USD	2 Qtrs
Proceeds from related party debt	`ProceedsFromRelatedPartyDebt`	-	USD	Annual
Proceeds from related party debt	`ProceedsFromRelatedPartyDebt`	$380.00	USD	6 Qtrs
Net Cash Provided by Financing Activities	`NetCashProvidedByUsedInFinancingActivities`	-	USD	Annual
Net Cash Provided by Financing Activities	`NetCashProvidedByUsedInFinancingActivities`	$55.38K	USD	6 Qtrs
Net Cash Provided by Financing Activities	`NetCashProvidedByUsedInFinancingActivities`	$55.38K	USD	2 Qtrs
Net Increase/ (Decrease) in Cash	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-35.11K	USD	Annual
Net Increase/ (Decrease) in Cash	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$47.42K	USD	2 Qtrs
Net Increase/ (Decrease) in Cash	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$12.31K	USD	6 Qtrs
Cash, Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$47.42K	USD	Point-in-time
Cash, Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$12.31K	USD	Point-in-time
Cash, Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	-	USD	Point-in-time
Cash, End of Period	`CashAndCashEquivalentsAtCarryingValue`	$47.42K	USD	Point-in-time
Cash, End of Period	`CashAndCashEquivalentsAtCarryingValue`	$12.31K	USD	Point-in-time
Cash, End of Period	`CashAndCashEquivalentsAtCarryingValue`	-	USD	Point-in-time
Interest paid	`InterestPaid`	-	USD	6 Qtrs
Interest paid	`InterestPaid`	-	USD	2 Qtrs
Interest paid	`InterestPaid`	-	USD	Annual
Income taxes paid	`IncomeTaxesPaidNet`	-	USD	2 Qtrs
Income taxes paid	`IncomeTaxesPaidNet`	-	USD	Annual
Income taxes paid	`IncomeTaxesPaidNet`	-	USD	6 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.